Provided by Tiger Trade Technology Pte. Ltd.

Ensysce Biosciences Inc.

0.3950
-0.0015-0.38%
Pre-market: 0.64370.2487+62.96%08:52 EST
Volume:1.52M
Turnover:573.51K
Market Cap:1.43M
PE:-0.06
High:0.4070
Open:0.4070
Low:0.3550
Close:0.3965
52wk High:5.72
52wk Low:0.3144
Shares:3.63M
Float Shares:3.12M
Volume Ratio:1.11
T/O Rate:48.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0968
EPS(LYR):-11.4482
ROE:-294.39%
ROA:-109.79%
PB:1.19
PE(LYR):-0.03

Loading ...

Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Correspondence

CORRESP [Cover] - Correspondence
Jan 13, 2023

Major Issues Report

8-K - Current report
Dec 27, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2022

Major Issues Report

8-K - Current report
Dec 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 08, 2022

Major Issues Report

8-K - Current report
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 05, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 01, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 18, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 17, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 16, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 27, 2022

Major Issues Report

8-K - Current report
Sep 20, 2022

Major Issues Report

8-K - Current report
Sep 16, 2022

Major Issues Report

8-K - Current report